Regarding the recent medical focus on personalized treatment, our results provide a significant cornerstone for further studies aimed to utilize MUC4 polymorphisms as individualized factors for CRC treatment and early diagnosis. The gene discussed is MUC4; the disease is colorectal carcinoma.